The Canadian doctor who helped invent Ozempic – Macleans.ca
Decades ago, Toronto researcher Daniel Drucker co-discovered a hormone that paved the way for today’s most-talked-about drug. Does he get the hype? Yes and no.
Decades ago, Toronto researcher Daniel Drucker co-discovered a hormone that paved the way for today’s most-talked-about drug. Does he get the hype? Yes and no.
In 2017, through the ISN Sister Renal Centers Program, staff from the nephrology section of the Alberta Children’s Hospital (ACH) in Alberta, Canada, began supporting…
An abstract is unavailable. This article is available as a PDF only.
ildcare due to nontraditional work hours with extended or unpredictable shifts. Here, we examine awareness of current policies in United States (US) nephrology fellowship programs…
The four Founding Collaborators designed and supported the development of the National Health Equity Grand Rounds series. We are grateful for the support of our…
Nature Reviews Nephrology – Here, the authors review the mechanisms that underlie cisplatin-induced acute kidney injury and chronic kidney disease. They also discuss the challenges…
of 519 biopsy-proven PLA2R-associated primary membranous nephropathy patients with baseline eGFR ≥25 ml/min per 1.73 m2. The combined risk score was calculated by combining the…
tions that support specific physiologic processes. However, the heterogeneity of human kidney endothelial cells has not yet been systematically described. Methods We reprocessed and integrated…
Demand for kidney grafts outpaces supply, limiting kidney transplantation as a treatment for kidney failure. Xenotransplantation has the potential to …
RPA’s Legislative Action Center (LAC) facilitates the important communication between RPA members and their members of Congress as well as representatives in their state legislatures.…